NM_000081.4:c.5023+41C>T
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000081.4(LYST):c.5023+41C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 1,343,810 control chromosomes in the GnomAD database, including 10,497 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000081.4 intron
Scores
Clinical Significance
Conservation
Publications
- Chediak-Higashi syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P
- attenuated Chédiak-Higashi syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LYST | ENST00000389793.7 | c.5023+41C>T | intron_variant | Intron 15 of 52 | 5 | NM_000081.4 | ENSP00000374443.2 | |||
LYST | ENST00000489585.5 | n.5023+41C>T | intron_variant | Intron 15 of 22 | 1 | ENSP00000513166.1 | ||||
LYST | ENST00000697178.1 | n.*447+41C>T | intron_variant | Intron 14 of 51 | ENSP00000513163.1 |
Frequencies
GnomAD3 genomes AF: 0.107 AC: 16254AN: 151952Hom.: 971 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.104 AC: 25707AN: 246368 AF XY: 0.104 show subpopulations
GnomAD4 exome AF: 0.122 AC: 145487AN: 1191738Hom.: 9528 Cov.: 17 AF XY: 0.120 AC XY: 72795AN XY: 605286 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.107 AC: 16250AN: 152072Hom.: 969 Cov.: 32 AF XY: 0.103 AC XY: 7645AN XY: 74352 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:2
- -
This variant is classified as Benign based on local population frequency. This variant was detected in 21% of patients studied by a panel of primary immunodeficiencies. Number of patients: 20. Only high quality variants are reported. -
not provided Benign:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at